487
Views
11
CrossRef citations to date
0
Altmetric
Review

Fumarate hydratase as a therapeutic target in renal cancer

, , , &
Pages 923-936 | Received 26 May 2020, Accepted 07 Jul 2020, Published online: 06 Oct 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Tao Shen, Haiyang Wang, Bin Tang, Guoping Zhu & Xiangting Wang. (2023) The impact of RNA binding proteins and the associated long non-coding RNAs in the TCA cycle on cancer pathogenesis. RNA Biology 20:1, pages 223-234.
Read now

Articles from other publishers (10)

Lorea Valcarcel-Jimenez & Christian Frezza. (2023) Fumarate hydratase (FH) and cancer: a paradigm of oncometabolism. British Journal of Cancer 129:10, pages 1546-1557.
Crossref
Megha Yadav, Blessi N. Uikey, Shantnu Singh Rathore, Priyanka Gupta, Diksha Kashyap, Chanchal Kumar, Dhananjay Shukla, Vijayamahantesh, Arvind Singh Chandel, Bharti Ahirwar, Ashish Kumar Singh, Shashi Shekhar Suman, Amit Priyadarshi & Ajay Amit. (2023) Role of cytokine in malignant T-cell metabolism and subsequent alternation in T-cell tumor microenvironment. Frontiers in Oncology 13.
Crossref
Zhao Yang, Jianwei Liu, Feng Xue, Lei Zhang, Hui Xue, Yeye Wu, Shilei Bai, Furong Du, Xiaoxuan Wang, Wanglong Deng, Chao Song & Kui Wang. (2023) Genomic landscape of Chinese patients with hepatocellular carcinoma using next-generation sequencing and its association with the prognosis. Annals of Hepatology 28:2, pages 100898.
Crossref
Michael F. Basin, Rebecca A. Sager, K. R. Seetharam Bhat & Gennady Bratslavsky. 2023. Integrating Multidisciplinary Treatment for Advanced Renal Cell Carcinoma. Integrating Multidisciplinary Treatment for Advanced Renal Cell Carcinoma 47 72 .
Neil Mendhiratta, Jibriel Noun, Michael Daneshvar & Ramaprasad Srinivasan. 2023. Integrating Multidisciplinary Treatment for Advanced Renal Cell Carcinoma. Integrating Multidisciplinary Treatment for Advanced Renal Cell Carcinoma 359 375 .
Giovanni Tossetta & Roberta Mazzucchelli. (2022) Pathology of Urologic Cancers. Cancers 14:15, pages 3751.
Crossref
Heng Zhang, Qiang Ju, Jing Ji & Yanjie Zhao. (2021) Pan-Cancer Analysis Reveals FH as a Potential Prognostic and Immunological Biomarker in Lung Adenocarcinoma. Disease Markers 2021, pages 1-13.
Crossref
Pavel Jakoube, Valentina Cutano, Juan M. González-Morena & Zuzana Keckesova. (2021) Mitochondrial Tumor Suppressors—The Energetic Enemies of Tumor Progression. Cancer Research 81:18, pages 4652-4667.
Crossref
Bradley R. Webster, Alexis Rompre-Brodeur, Michael Daneshvar, Roma Pahwa & Ramaprasad Srinivasan. (2021) Kidney cancer: from genes to therapy. Current Problems in Cancer 45:4, pages 100773.
Crossref
Congwang Zhang, Lijun Li, Yipeng Zhang & Changchun Zeng. (2021) Hereditary Leiomyomatosis and Renal Cell Cancer: Recent Insights Into Mechanisms and Systemic Treatment. Frontiers in Oncology 11.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.